Saturday, June 13, 2026
🇺🇸 FDA

pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma

Chinese Academy of

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Chinese Academy of clinical programs — 1328 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
China, TAIZHOU, CN HQ
170 Employees
NMPA registrant Type
Company details
Status
Public
HQ
China, TAIZHOU, CN
Employees
170
Programs
1328
Drugs
711
Patents
335
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Chinese Academy of projects

1,328 ClinicalTrials.gov programs sponsored by Chinese Academy of.

Chinese Academy of has 1,328 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,328 programs

Clinical programs

Page 7 of 28

  1. Colchicine 0.5mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cerebral Amyloid Angiopathy

    phase 2 small molecule active

    1 trial

  2. Cyclophosphamide+Pemetrexed+5-Fluorouracil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Locally Advanced Thyroid Gland Carcinoma

    phase 2 small molecule active

    1 trial

  3. DAAOI-P

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Parkinson's Disease With Dementia

    phase 2 small molecule completed

    1 trial

  4. DEB-TACE+HAIC

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma Non-resectable

    phase 2 small molecule active

    1 trial

  5. DNA vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AIDS

    phase 2 mab completed

    1 trial

  6. Danggui Buxue Tang

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 2 small molecule active

    1 trial

  7. Daratumumab Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia

    phase 2 small molecule active

    2 trials

  8. Decitabine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML

    phase 2 small molecule terminated

    1 trial

  9. Denosumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    phase 2 small molecule active

    1 trial

  10. Dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ITP

    phase 2 small molecule active

    1 trial

  11. Dexamethasone Combined with romiplostim N01

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  12. Dose-attenuated IST and Hetrombopag

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sever Aplastic Anaemia

    phase 2 small molecule active

    1 trial

  13. EBV-TCR-T (YT-E001) cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 2 mab active

    1 trial

  14. EGFR-TK Inhibitor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nonsmall Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  15. Eculizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Kidney Transplantation

    phase 2 small molecule active

    1 trial

  16. Efbemalenograstim alfa Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary/Secondary Prevention

    phase 2 small molecule active

    1 trial

  17. Eltrombopag

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chemotherapy-induced Thrombocytopenia

    phase 2 small molecule active

    1 trial

  18. Eltrombopag

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thrombocytopenia Purpura

    phase 2 small molecule completed

    1 trial

  19. Endostar

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Neoplasms

    phase 2 small molecule active

    2 trials

  20. Engineered Mitochondrial Vaccine (IMP3-Mito)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 mab active

    1 trial

  21. Enoxaparin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pregnancy Related

    phase 2 small molecule active

    1 trial

  22. Ensartinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  23. Ensartinib group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC

    phase 2 small molecule active

    1 trial

  24. Epo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Premature Infant

    phase 2 small molecule terminated

    1 trial

  25. Erlotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-small-cell Lung Cancer

    phase 2 small molecule active

    1 trial

  26. Erythropoietin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Premature Infants

    phase 2 small molecule completed

    1 trial

  27. Etoposide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    phase 2 small molecule active

    1 trial

  28. FOLFOX/FOLFIRI

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unresectable or Metastatic Colorectal Cancer

    phase 2 small molecule active

    1 trial

  29. FOLFOXIRI

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colon Cancer

    phase 2 small molecule active

    1 trial

  30. FOLFOXIRI-based HAIC+Fuquinitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Neoplasms

    phase 2 small molecule completed

    1 trial

  31. Famitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Small Cell Lung Cancer (NSCLC)

    phase 2 small molecule on hold

    1 trial

  32. Favipiravir

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Influenza, Human

    phase 2 small molecule completed

    1 trial

  33. Fecal microbiota transplantation (FMT)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Slow Transit Constipation

    phase 2 small molecule active

    1 trial

  34. FirstHCMU-JBi-PARTOM

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Castration-resistant Prostate Cancer

    phase 2 small molecule active

    1 trial

  35. Fludarabine (FLU)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aplastic Anemia Idiopathic

    phase 2 small molecule active

    1 trial

  36. Freeze-dried, Capsulized FMT

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Slow Transit Constipation

    phase 2 other active

    1 trial

  37. Fruquintinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Cancer

    phase 2 small molecule active

    1 trial

  38. Fruquintinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Fruquintinib

    phase 2 small molecule active

    1 trial

  39. Furmonertinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Adenocarcinoma Stage III

    phase 2 small molecule active

    1 trial

  40. Furmonertinib in combination with Anrotinib and chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  41. GSPE

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atherosclerosis of Arteries of the Extremities, Unspecified

    phase 2 small molecule completed

    1 trial

  42. GT719 Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hematological Malignancy (Leukemia- Lymphoma)

    phase 2 mab active

    1 trial

  43. GVM±R regimen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral T Cell Lymphoma

    phase 2 small molecule active

    1 trial

  44. Gastrografin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Fecal Impaction

    phase 2 small molecule active

    1 trial

  45. Gecacitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    cGVHD

    phase 2 small molecule active

    1 trial

  46. Gemcitabine , Docetaxel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sarcoma

    phase 2 small molecule completed

    1 trial

  47. Gemcitabine 1000 mg

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Phase II, Open-label, Parallel 2-arm, Multi-center

    phase 2 small molecule active

    1 trial

  48. Gemcitabine Oxaliplatin 5FU and Leucovorin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Chinese Academy of have?

1,328 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.